dc.description.abstract | Background: Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) that
has poor solubility that can cause irritation and gastrointestinal disorders. Xanthan
gum is one of the natural polymers that provides good characteristics and stability.
Therefore, ketoprofen is formulated into a nanosuspension preparation with the
addition of natural polymer xanthan gum.
Objective: To formulate ketoprofen nanosuspension preparation with xanthan gum
polymer, characterize the preparation and compare the dissolution test with
ketoprofen suspension.
Method: Preparation of ketoprofen nanosuspension using evaporativeprecipitation
method with Tween 80 surfactant and variation of xanthan gum
polymer concentration F1 (0.05%), F2 (0.25%), F3 (0.5%). The characterization of
the preparation includes organoleptic test, determination of particle size, zeta
potential, and polydispersity index, measurement of pH, specific gravity, viscosity,
content and dissolution test of the preparation, and observing the stability of the
preparation for 3 months at room temperature storage (25C).
Results: Ketoprofen can be formulated into nanosuspension with xanthan gum
polymer. The particle sizes of ketoprofen nanosuspension in F1, F2, F3 are
15,620,24 nm; 16,740,17 nm; 18,640,36 nm, with zeta potential >-30mV and
polydispersity index value >0.2. The preparation has a pH of 4.6-5.0; specific
gravity >1 g/mL; and viscosity of 20-32 cP. The preparation showed stability during
3 months storage. However, there was a decrease in pH, particle size, zeta potential,
polydispersity index, specific gravity, viscosity and content. The dissolution results
with % cumulative at the 60th minute were 83.75%; 81.28%; 80.18% respectively,
showing faster results than ketoprofen suspension with % cumulative 12.13%.
Conclusion: Ketoprofen nanosuspension can be made with gom xanthan polymer.
There is an effect of concentration variation in gom xanthan polymer on the
characterization of ketoprofen nanosuspension preparation with the best
nanosuspension results at a concentration of 0.05%. The formulated
nanosuspension showed faster release compared to ketoprofen suspension. | en_US |